Pre-approved travelers use dedicated lanes, known as express lanes, to avoid long inspection lines at the bridges, the U.S.
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
El Paso Matters Staff January 29, 2025 Edward Greer, who enlisted in the segregated Army during World War II and rose to ...
A key component of Mexico avoiding threatened Feb. 1 Trump administration tariffs on exports to the United States is that ...